Cynata Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	52	19	33	14	34	46
Market Cap Growth	46.03%	-42.66%	141.05%	-59.73%	-25.70%	4.38%
Enterprise Value	49	13	26	4	16	30
Last Close Price	0.19	0.06	0.15	0.05	0.22	0.27
PS Ratio	49.63	17.98	22.88	13.57	6.64	46.80
PB Ratio	15.64	5.67	7.34	1.34	2.15	2.55
P/TBV Ratio	15.64	5.67	7.34	1.34	2.15	2.55
EV/Sales Ratio	43.49	12.41	18.06	3.65	3.19	30.68
Net Debt / Equity Ratio	-0.84	-0.84	-0.86	-0.97	-0.99	-0.94
Net Debt / EBITDA Ratio	0.54	0.54	0.62	1.11	4.11	3.68
Asset Turnover	0.24	0.24	0.17	0.07	0.28	0.07
Quick Ratio	4.24	4.24	5.39	7.30	9.23	16.71
Current Ratio	4.40	4.40	5.58	7.46	9.33	17.03
Return on Equity (ROE)	-142.29%	-142.29%	-81.37%	-70.17%	-20.81%	-34.05%
Return on Assets (ROA)	-77.08%	-77.08%	-46.70%	-40.86%	-13.42%	-19.85%
Return on Capital Employed (ROCE)	-160.70%	-160.70%	-141.70%	-89.00%	-25.30%	-26.60%
Earnings Yield	-10.04%	-27.71%	-18.39%	-63.59%	-10.56%	-10.63%
Buyback Yield / Dilution	-14.10%	-14.09%	-23.80%	-1.27%	-9.85%	-24.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.